Appili Therapeutics Inc.
APLIF
$0.01
$0.0026.39%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -58.62% | -10.36% | 4.80% | 20.49% | -668.41% |
| Total Depreciation and Amortization | 11.11% | -- | -100.00% | -7.69% | 18.18% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -4.15% | 71.67% | 363.56% | -158.63% | -82.20% |
| Change in Net Operating Assets | 299.91% | -26.57% | 22.37% | -69.22% | 651.39% |
| Cash from Operations | 87.61% | -4.58% | 63.60% | -11,884.78% | -100.64% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -273.08% | 533.33% | 98.01% | -2.73% | 34.74% |
| Issuance of Common Stock | -- | -43.66% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 830.85% | 168.61% | 42.07% | -263.85% | 20.73% |
| Cash from Financing | 37.57% | -18.56% | 290.75% | -83.66% | 28.17% |
| Foreign Exchange rate Adjustments | -1,431.25% | 60.00% | -109.11% | 211.42% | -181.91% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 155.96% | -27.38% | 82.70% | -655.63% | -110.27% |